Pharmacological hyperprolactinemia attenuates hydrocortisone-induced expression of CD11b on human CD8+ cells in vivo

NeuroImmunoModulation

Volumn 11, Issue 3, 2004, Pages 133-140

  Imrich, Richard ^a   Tibenska, Elena ^b   Koska, Juraj ^a   Rovensky, Jozef ^c   Vigas, Milan ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b University Pediatric Hospital   (Slovakia)

^c NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Cd11b+CD8+; Cortisol; Hyperprolactinemia; Hypothalamic pituitary adrenal axis; Lymphocyte subsets; Prolactin

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; COSTI; DOMPERIDONE; GAMMA INTERFERON; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; IONOMYCIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLACEBO; PROLACTIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HYPERPROLACTINEMIA; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LEUKOCYTE COUNT; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD11; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; DOMPERIDONE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; GRANULOCYTES; HUMANS; HYDROCORTISONE; HYPERPROLACTINEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE SUBSETS; MONOCYTES; PITUITARY-ADRENAL SYSTEM; PROLACTIN; UP-REGULATION;

EID: 1842559501     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076762     Document Type: Article

References (37)

1. Matera L: Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996;59:599-614.
2. Matera L: Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation 1997;4:171-180.
3. Bresson JL, Jeay S, Gagnerault MC, Kayser C, Beressi N, Wu Z, Kinet S, Dardenne M, Postel-Vinay MC: Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: Relation with age and GH-binding protein. Endocrinology 1999;140:3203-3209.
4. Pellegrini I, Lebrun JJ, Ali S, Kelly PA: Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992;6:1023-1031.
5. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE: Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine. J Immunol 1985;134:3027-3031.
6. Foster MP, Jensen ER, Montecino-Rodriguez E, Leathers H, Horseman N, Dorshkind K: Humoral and cell-mediated immunity in mice with genetic deficiencies of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormone. Clin Immunol 2000;96:140-149.
7. Chikanza IC, Grossman AB: Reciprocal interactions between the neuroendocrine and immune systems during inflammation. Rheum Dis Clin North Am 2000;26:693-711.
8. Almawi WY, Melemedjian OK, Rieder MJ: An alternate mechanism of glucocorticoid antiproliferative effect: Promotion of a Th2 cytokine-secreting profile. Clin Transplant 1999;13:365-374.
9. Imrich R, Rovensky J, Cervenakova Z, Ksinantova L, Kvetnansky R, Koska J: Hyperprolactinemia does not influence hypothalamicpituitary-adrenocortical function during hypoglycemia in women. Int J Tissue React 2002;24:73-78.
10. Dorshkind K, Horseman ND: The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 2000;21:292-312.
11. Cwikel S, Silvian-Drachsler I, Prolov L, Hooghe-Peters EL, Merchav S: Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors. Exp Hematol 2001;29:937-942.
12. Stocklin E, Wissler M, Gouilleux F, Groner B: Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996;383:726-728.
13. Bauer ME, Perks P, Lightman SL, Shanks N: Are adhesion molecules involved in stressinduced changes in lymphocyte distribution? Life Sci 2001;69:1167-1179.
14. Fauci AS: Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol 1976;24:54-62.
15. Pitzalis C, Pipitone N, Bajocchi G, Hall M, Goulding N, Lee A, Kingsley G, Lanchbury J, Panayi G: Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: An additional mechanism for their antiinflammatory and immunosuppressive effect. J Immunol 1997;158:5007-5016.
16. Burton JL, Kehrli ME Jr: Regulation of neutrophil adhesion molecules and shedding of Staphylococcus aureus in milk of cortisol- and dexamethasone- treated cows. Am J Vet Res 1995;56:997-1006.
17. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992;89:9991-9995.
18. Rovensky J, Buc M, Lojda Z, Ruzickova M, Blazickova S, Rauova L, Mistina T, Vigas M, Lackovic V: Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp (Warsz) 1995;43:221-227.
19. Connelly MC, Knight M, Giorgi JV, Kagan J, Landay AL, Parker JW, Page E, Spino C, Wilkening C, Mercolino TJ: Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the Ortho Cytoron-Absolute flow cytometry system on normal donors. Cytometry 1995;22:200-210.
20. Horvathova M, Ferencik M: The role of adhesion molecules in the immune system (in Slovak). Bratisl Lek Listy 2000;101:138-145.
21. Fassbender K, Kaptur S, Becker P, Groschel J, Schmidt R, Hennerici M: Inverse association between endogenous glucocorticoid secretion and L-selectin (CD62L) expression in trauma patients. Life Sci 1999;65:2471-2480.
22. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755.
23. Jilma B, Voltmann J, Albinni S, Stohlawetz P, Schwarzinger I, Gleiter CH, Rauch A, Eichler HG, Wagner OF: Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther 1997;62:562-568.
24. Amenta F, Bronzetti E, Felici L, Ricci A, Tayebati SK: Dopamine D2-like receptors on human peripheral blood lymphocytes: A radioligand binding assay and immunocytochemical study. J Auton Pharmacol 1999;19:151-159.
25. Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L: Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol 2001;31:3504-3512.
26. Fiserova A, Starec M, Kuldova M, Kovaru H, Pav M, Vannucci L, Pospisil M: Effects of D2-dopamine and alpha-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice. J Neuroimmunol 2002;130:55-65.
27. Daynes RA, Araneo BA: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
28. Moynihan JA, Karp JD, Cohen N, Cocke R: Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids. J Neuroimmunol 1994;54:51-58.
29. Araneo BA, Dowell T, Moon HB, Daynes RA: Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism. J Immunol 1989;143:1737-1744.
30. Montgomery DW: Prolactin production by immune cells. Lupus 2001;10:665-675.
31. Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q: Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
32. Walker SE, Jacobson JD: Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000;26:713-736.
33. Masi AT, Chrousos GP: Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol 1996;23:577-581.
34. Masi AT, Chrousos GP, Bornstein SR: Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. J Rheumatol 1999;26:247-250.
35. Rovensky J, Bakosova J, Payer J, Lukac J, Raffayova H, Vigas M: Increased demand for steroid therapy in hyperprolactinemic patients with rheumatoid arthritis. Int J Tissue React 2001;23:145-149.
36. Suzuki S, Toyabe S, Moroda T, Tada T, Tsukahara A, Iiai T, Minagawa M, Maruyama S, Hatakeyama K, Endoh K, Abo T: Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 1997;110:500-508.
37. Terao K, Suzuki J, Ohkura S: Circadian rhythm in circulating CD16-positive natural killer (NK) cells in macaque monkeys, implication of plasma cortisol levels. Primates 2002;43:329-338.